Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Florence Mishellany

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 5, 2009
Ovarian epithelial dysplasia and prophylactic oophorectomy for genetic riskGautier Chêne, Frederique Penault-Llorca, Guillaume Le Bouëdec, et al.
American Journal of Cancer Research|May 5, 2021
New insight into the role of ANXA1 in melanoma progression: involvement of stromal expression in disseminationSolène Delorme, Maud Privat, Nicolas Sonnier, et al.
Epigenomics|October 17, 2018
TIP60: an actor in acetylation of H3K4 and tumor development in breast cancerGaëlle Judes, Lucas Dubois, Khaldoun Rifaï, et al.
Oncotarget|February 18, 2016
Targeting DNA repair by coDbait enhances melanoma targeted radionuclide therapyClaire Viallard, Jean-Michel Chezal, Florence Mishellany, et al.
European Journal of Dermatology : EJD|December 31, 2014
[¹²³I]ICF01012 melanoma imaging and [¹³¹I]ICF01012 dosimetry allow adapted internal targeted radiotherapy in preclinical melanoma modelsClaire Viallard, Yann Perrot, Zied Boudhraa, et al.
Neoplasia (New York, N.Y.)|December 18, 2016
Theranostic Approach for Metastatic Pigmented Melanoma Using ICF15002, a Multimodal Radiotracer for Both PET Imaging and Targeted Radionuclide TherapyLatifa Rbah-Vidal, Aurélien Vidal, Emilie M F Billaud, et al.
International Journal of Cancer|May 14, 2009
Targeted radionuclide therapy of melanoma: anti-tumoural efficacy studies of a new 131I labelled potential agentMathilde Bonnet-Duquennoy, Janine Papon, Florence Mishellany, et al.
International Journal of Cancer|February 14, 2013
In vivo efficacy of melanoma internal radionuclide therapy with a 131I-labelled melanin-targeting heteroarylcarboxamide moleculeFrançoise Degoul, Michèle Borel, Nathalie Jacquemot, et al.
Gynecologic Oncology|September 16, 2022
Uterine sarcomas and rare uterine mesenchymal tumors with malignant potential. Diagnostic guidelines of the French Sarcoma Group and the Rare Gynecological Tumors GroupSabrina Croce, Mojgan Devouassoux-Shisheboran, Patricia Pautier, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 28, 2019
Genomic and transcriptomic comparison of post-radiation versus sporadic sarcomasTom Lesluyes, Jessica Baud, Gaëlle Pérot, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 5, 2009
Ovarian epithelial dysplasia and prophylactic oophorectomy for genetic riskGautier Chêne, Frederique Penault-Llorca, Guillaume Le Bouëdec, et al.
American Journal of Cancer Research|May 5, 2021
New insight into the role of ANXA1 in melanoma progression: involvement of stromal expression in disseminationSolène Delorme, Maud Privat, Nicolas Sonnier, et al.
Epigenomics|October 17, 2018
TIP60: an actor in acetylation of H3K4 and tumor development in breast cancerGaëlle Judes, Lucas Dubois, Khaldoun Rifaï, et al.
Oncotarget|February 18, 2016
Targeting DNA repair by coDbait enhances melanoma targeted radionuclide therapyClaire Viallard, Jean-Michel Chezal, Florence Mishellany, et al.
European Journal of Dermatology : EJD|December 31, 2014
[¹²³I]ICF01012 melanoma imaging and [¹³¹I]ICF01012 dosimetry allow adapted internal targeted radiotherapy in preclinical melanoma modelsClaire Viallard, Yann Perrot, Zied Boudhraa, et al.
Neoplasia (New York, N.Y.)|December 18, 2016
Theranostic Approach for Metastatic Pigmented Melanoma Using ICF15002, a Multimodal Radiotracer for Both PET Imaging and Targeted Radionuclide TherapyLatifa Rbah-Vidal, Aurélien Vidal, Emilie M F Billaud, et al.
International Journal of Cancer|May 14, 2009
Targeted radionuclide therapy of melanoma: anti-tumoural efficacy studies of a new 131I labelled potential agentMathilde Bonnet-Duquennoy, Janine Papon, Florence Mishellany, et al.
International Journal of Cancer|February 14, 2013
In vivo efficacy of melanoma internal radionuclide therapy with a 131I-labelled melanin-targeting heteroarylcarboxamide moleculeFrançoise Degoul, Michèle Borel, Nathalie Jacquemot, et al.
Gynecologic Oncology|September 16, 2022
Uterine sarcomas and rare uterine mesenchymal tumors with malignant potential. Diagnostic guidelines of the French Sarcoma Group and the Rare Gynecological Tumors GroupSabrina Croce, Mojgan Devouassoux-Shisheboran, Patricia Pautier, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 28, 2019
Genomic and transcriptomic comparison of post-radiation versus sporadic sarcomasTom Lesluyes, Jessica Baud, Gaëlle Pérot, et al.
Pageof 3